151 related articles for article (PubMed ID: 3258773)
1. Modulation of nitrosourea resistance in myeloid leukemias.
Gerson SL; Trey JE
Blood; 1988 May; 71(5):1487-94. PubMed ID: 3258773
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of nitrosourea cytotoxicity in human leukemic cells by inactivation of O6-alkylguanine-DNA alkyltransferase.
Gerson SL; Trey JE; Miller K
Cancer Res; 1988 Mar; 48(6):1521-7. PubMed ID: 3162197
[TBL] [Abstract][Full Text] [Related]
3. Human CD34+ hematopoietic progenitors have low, cytokine-unresponsive O6-alkylguanine-DNA alkyltransferase and are sensitive to O6-benzylguanine plus BCNU.
Gerson SL; Phillips W; Kastan M; Dumenco LL; Donovan C
Blood; 1996 Sep; 88(5):1649-55. PubMed ID: 8781420
[TBL] [Abstract][Full Text] [Related]
4. Modulation of nitrosourea resistance in human colon cancer by O6-methylguanine.
Gerson SL; Berger NA; Arce C; Petzold SJ; Willson JK
Biochem Pharmacol; 1992 Mar; 43(5):1101-7. PubMed ID: 1554383
[TBL] [Abstract][Full Text] [Related]
5. Retroviral transduction and expression of the human alkyltransferase cDNA provides nitrosourea resistance to hematopoietic cells.
Allay JA; Dumenco LL; Koc ON; Liu L; Gerson SL
Blood; 1995 Jun; 85(11):3342-51. PubMed ID: 7756667
[TBL] [Abstract][Full Text] [Related]
6. Modulation of human lymphocyte O6-alkylguanine-DNA alkyltransferase by streptozotocin in vivo.
Gerson SL
Cancer Res; 1989 Jun; 49(11):3134-8. PubMed ID: 2524250
[TBL] [Abstract][Full Text] [Related]
7. O6-alkylguanine-DNA alkyltransferase. A target for the modulation of drug resistance.
Gerson SL; Willson JK
Hematol Oncol Clin North Am; 1995 Apr; 9(2):431-50. PubMed ID: 7642472
[TBL] [Abstract][Full Text] [Related]
8. Synergistic efficacy of O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in a human colon cancer xenograft completely resistant to BCNU alone.
Gerson SL; Zborowska E; Norton K; Gordon NH; Willson JK
Biochem Pharmacol; 1993 Jan; 45(2):483-91. PubMed ID: 8435098
[TBL] [Abstract][Full Text] [Related]
9. Repair of O6-alkylguanine during DNA synthesis in murine bone marrow hematopoietic precursors.
Gerson SL; Trey JE; Miller K; Benjamin E
Cancer Res; 1987 Jan; 47(1):89-95. PubMed ID: 3539320
[TBL] [Abstract][Full Text] [Related]
10. Increased killing of prostate, breast, colon, and lung tumor cells by the combination of inactivators of O6-alkylguanine-DNA alkyltransferase and N,N'-bis(2-chloroethyl)-N-nitrosourea.
Pegg AE; Swenn K; Chae MY; Dolan ME; Moschel RC
Biochem Pharmacol; 1995 Oct; 50(8):1141-8. PubMed ID: 7488227
[TBL] [Abstract][Full Text] [Related]
11. O6-methylguanine-DNA methyltransferase (MGMT) transfectants of a 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-sensitive colon cancer cell line selectively repopulate heterogenous MGMT+/MGMT- xenografts after BCNU and O6-benzylguanine plus BCNU.
Phillips WP; Willson JK; Markowitz SD; Zborowska E; Zaidi NH; Liu L; Gordon NH; Gerson SL
Cancer Res; 1997 Nov; 57(21):4817-23. PubMed ID: 9354444
[TBL] [Abstract][Full Text] [Related]
12. Point mutations in human O6-alkylguanine-DNA alkyltransferase prevent the sensitization by O6-benzylguanine to killing by N,N'-bis (2-chloroethyl)-N-nitrosourea.
Loktionova NA; Pegg AE
Cancer Res; 1996 Apr; 56(7):1578-83. PubMed ID: 8603405
[TBL] [Abstract][Full Text] [Related]
13. Selection for G156A O6-methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and protection from lethality in mice treated with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea.
Davis BM; Reese JS; Koç ON; Lee K; Schupp JE; Gerson SL
Cancer Res; 1997 Nov; 57(22):5093-9. PubMed ID: 9371508
[TBL] [Abstract][Full Text] [Related]
14. O6-alkylguanine DNA-alkyltransferase is not a major determinant of sensitivity to 1,3-bis(2-chloroethyl)-1-nitrosourea in four medulloblastoma cell lines.
Silber JR; Bobola MS; Ewers TG; Muramoto M; Berger MS
Oncol Res; 1992; 4(6):241-8. PubMed ID: 1421617
[TBL] [Abstract][Full Text] [Related]
15. The role of O6-alkylguanine DNA alkyltransferase in limiting nitrosourea-induced sister chromatid exchanges in proliferating human lymphocytes.
Trey JE; Gerson SL
Cancer Res; 1989 Apr; 49(8):1899-903. PubMed ID: 2702633
[TBL] [Abstract][Full Text] [Related]
16. Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea.
Liu L; Markowitz S; Gerson SL
Cancer Res; 1996 Dec; 56(23):5375-9. PubMed ID: 8968088
[TBL] [Abstract][Full Text] [Related]
17. Modulation of O6-alkylguanine-DNA alkyltransferase in rats following intravenous administration of O6-methylguanine.
Dexter EU; Yamashita TS; Donovan C; Gerson SL
Cancer Res; 1989 Jul; 49(13):3520-4. PubMed ID: 2731174
[TBL] [Abstract][Full Text] [Related]
18. Combined depletion of O6-alkylguanine-DNA alkyltransferase and glutathione to modulate nitrosourea resistance in breast cancer.
Gerson SL; Berger SJ; Varnes ME; Donovan C
Biochem Pharmacol; 1994 Aug; 48(3):543-8. PubMed ID: 8068041
[TBL] [Abstract][Full Text] [Related]
19. O6-Benzylguanine potentiates BCNU but not busulfan toxicity in hematopoietic stem cells.
Westerhof GR; Down JD; Blokland I; Wood M; Boudewijn A; Watson AJ; McGown AT; Ploemacher RE; Margison GP
Exp Hematol; 2001 May; 29(5):633-8. PubMed ID: 11376877
[TBL] [Abstract][Full Text] [Related]
20. Regeneration of O6-alkylguanine-DNA alkyltransferase in human lymphocytes after nitrosourea exposure.
Gerson SL
Cancer Res; 1988 Sep; 48(18):5368-73. PubMed ID: 3409258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
